Spiros Efthimiopoulos
- Physiology top 2%
- Molecular Biology top 10%
- Pharmacology top 2%
- Cellular and Molecular Neuroscience top 5%
- Oncology top 10%
- Co-authors
- Nikolaos K. RobakisJunichi ShioiMarigoula MargarityFotini N. LamariPaul CordopatisMaria TsachakiMiguel A. PappollaDiane L. Hickson‐Bick
- Topics
- Alzheimer's disease research and treatments (42 papers)Cholinesterase and Neurodegenerative Diseases (11 papers)Cellular transport and secretion (10 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Neuroscience
- Partner nations
- GreeceUnited StatesSwitzerland
In The Last Decade
Spiros Efthimiopoulos
54 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 102
- Physiology 1.2k
- Molecular Biology 1.1k
- Pharmacology 467
- Cellular and Molecular Neuroscience 424
- Oncology 393
Countries citing papers authored by Spiros Efthimiopoulos
This map shows the geographic impact of Spiros Efthimiopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spiros Efthimiopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spiros Efthimiopoulos more than expected).
Fields of papers citing papers by Spiros Efthimiopoulos
This network shows the impact of papers produced by Spiros Efthimiopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spiros Efthimiopoulos. The network helps show where Spiros Efthimiopoulos may publish in the future.
Co-authorship network of co-authors of Spiros Efthimiopoulos
This figure shows the co-authorship network connecting the top 25 collaborators of Spiros Efthimiopoulos. A scholar is included among the top collaborators of Spiros Efthimiopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spiros Efthimiopoulos. Spiros Efthimiopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | BRI2 Interacts with BACE1 and Reduces its Cellular Levels by Reducing the Levels of BACE1 mRNA and Inducing its Degradation Through the Lysosomal Pathway. | 1 |
| 3 | 18 | |
| 4 | 161 | |
| 5 | 34 | |
| 6 | 40 | |
| 7 | 29 | |
| 8 | 25 | |
| 9 | 13 | |
| 10 | 181 | |
| 11 | 17 | |
| 12 | 40 | |
| 13 | 27 | |
| 14 | 37 | |
| 15 | 32 | |
| 16 | 51 | |
| 17 | 7 | |
| 18 | 29 | |
| 19 | 22 | |
| 20 | 6 |
About Spiros Efthimiopoulos
Spiros Efthimiopoulos is a scholar working on Physiology, Cell Biology and Pharmacology, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (42 papers), Cholinesterase and Neurodegenerative Diseases (11 papers) and Cellular transport and secretion (10 papers). The work is most often cited by research in Physiology (1.2k citations), Biological Psychiatry (84 citations) and Pharmacology (467 citations). Spiros Efthimiopoulos has collaborated with scholars based in Greece, United States and Switzerland. Frequent co-authors include Nikolaos K. Robakis, Junichi Shioi, Marigoula Margarity, Fotini N. Lamari, Paul Cordopatis, Maria Tsachaki, Miguel A. Pappolla, Diane L. Hickson‐Bick, Roger J. Bick and Rüssel J. Reiter. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.